China AI Biotech Firm Raises $200 Million in Oman-Backed Round
Reported by Bloomberg, Securities.io, FourWeekMBA and 1 more outlets4 sources ↓
MegaRobo raised nearly $200 million in a round joined by Oman’s sovereign wealth fund. The company says the proceeds will support research and development and global expansion.
Key points
- The round brings MegaRobo’s total funding to about $600 million, according to aiweekly and Securities.io
- Oman Investment Authority and CMB International joined the round; Asia Investment Capital, Granite Asia and Sinovation Ventures continued
- MegaRobo filed for a Hong Kong listing in 2025 and remains in the IPO queue, aiweekly reports
Sources
- BloombergRead ↗China AI Biotech Firm Raises $200 Million in Oman-Backed Round
- Securities.ioRead ↗MegaRobo Secures Nearly US$200 Million In OIA-Backed Financing
- FourWeekMBARead ↗Oman Backs MegaRobo’s ~$200M Round, a Third of Its Total
- aiweeklyRead ↗MegaRobo raises ~$200M from Oman fund for AI lab robotics
Details
The Beijing-based company announced the financing on November 18, 2026, according to Securities.io. Bloomberg’s report, summarized by aiweekly, describes the round as close to $200 million. The articles do not specify the amount contributed by Oman Investment Authority.
MegaRobo makes AI and robotics systems for laboratory workflows, including drug screening. Aiweekly reports that about 80% of the company’s revenue still comes from China; it also says CEO Daniel Huang identified Belt and Road markets as an area of overseas growth opportunity.
Written from coverage as of
Images
- Securities.io